24.03.2017 • News

India May Have Concerns on DowDuPont

(c) Dow Chemicals
(c) Dow Chemicals

Just as news agencies and the CEOs of and DuPont had begun reporting that the merger of the two US chemical powerhouses was close to receiving all regulatory approvals, antitrust authorities in India have announcd they have concerns about the $130 billion deal.

In a statement on Mar. 22, the Competition Commission of India (CCI) said it is “of the prima facie opinion that the proposed combination between Dow Chemical Company and E. I. du Pont de Nemours and Company is likely to have an appreciable adverse effect on competition."

The authority has not been explicit about its concerns but said it has sought public opinion on the deal and has directed the two companies to publish details of their proposed merger.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read